Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to bolster manufacturing in the U.S., the report said.

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street ...

Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people with overweight or ...

Approximately 7,100 people are employed in biotechnology, nearly two-thirds of them in smaller companies of fewer than 50 employees. Industry leaders are unanimous in crediting two Seattle ...

A critical avenue of U.S.-China competition has slipped under the public's radar despite its potential outsize impacts on economies, militaries and weaponry: biotechnology. Why it matters: Better body ...